Circulation

APRIL 13, 2025

Heart failure is a growing health-care concern affecting tens of millions of individuals globally. Although traditional therapeutic strategies have focused on reducing the risk for hospitalization and mortality, the importance of patient-reported outcomes (PROs) in patients with heart failure is increasingly being recognized.

Heart Failure 81

Heart Failure Outcomes Article Cardiomyopathy 81

Med Page Today

MARCH 21, 2024

(MedPage Today) -- How patients with acute decompensated heart failure (HF) perceived the financial challenges of their healthcare played out in their health outcomes, despite receiving life-prolonging medications, a prospective study from China.

Heart Failure 105

Heart Failure Outcomes 105

Cardiology Update

AUGUST 4, 2024

Despite proven benefits in reducing morbidity and mortality, many heart failure (HF) patients do not receive optimal guideline-directed medical therapy (GDMT). ESC Heart Failure 2024; 11 : 560–569. The post Digital Consults to Enhance Heart Failure Treatment: The ADMINISTER Trial appeared first on Cardiology Update.

Heart Failure 119

Heart Failure ACE Inhibitor COVID-19 Quality of Life 119

Heart BMJ

JANUARY 29, 2025

Background We evaluated the potential of circulating bone morphogenetic protein 10 (BMP10) as a biomarker for atrial stress and remodelling in patients with heart failure (HF), in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP). We also assessed the predictive value of BMP10 for adverse clinical outcomes.

Heart Failure 52

Heart Failure Circulation Biomarkers Atrial Fibrillation 52

Heart BMJ

FEBRUARY 12, 2025

Background Atrial arrhythmias (AA) and heart failure (HF) are major causes of hospitalisation in adult congenital heart disease (ACHD). Dates of first AA and HF presentations were documented, and outcomes of RFA, including acute and long-term success, were assessed.

Congenital Heart Disease 59

Congenital Heart Disease Heart Failure Congenital Arrhythmia 59

Frontiers in Cardiovascular Medicine

MARCH 5, 2025

The association between ACC and clinical outcomes in HF patients was analyzed using Cox proportional hazards regression and restricted cubic spline models.ResultsA total of 4,737 heart failure patients were included. Patients were stratified into three groups based on ACC levels.

Heart Failure 52

Heart Failure Hospital Outcomes Research 52

The British Journal of Cardiology

APRIL 2, 2025

Heart failure (HF) is a highly prevalent long-term condition, with variation in services and resources across the UK. Studies are needed to determine if they are adequately resourced to meet population needs and improve patient outcomes. Eighty-five responses describing community HF services were received.

Heart Failure 40

Heart Failure Preserved Ejection Fraction Nursing Pharmacology 40

Frontiers in Cardiovascular Medicine

JANUARY 19, 2025

AimThe association between red cell distribution widthalbumin ratio (RAR) and the risk of all-cause mortality in intensive care unit (ICU) patients with heart failure remains uncertain. database was utilized for the analysis of ICU patients with heart failure.

Heart Failure 52

Heart Failure ICU Physiology Outcomes 52

Cardiology Update

APRIL 25, 2024

RELIEVE-HF investigators evaluated the efficacy and safety of the V-wave interatrial shunt system in patients with heart failure. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. April 6, 2024.

Heart Failure 98

Heart Failure Heart Transplant Transplant Research 98

Heart BMJ

MARCH 26, 2025

Heart failure (HF) is one of the significant complications in patients with myocardial infarction (MI), leading to increased risk for cardiovascular morbidity and mortality. 2 Therefore, early identification of HF in high-risk populations, particularly post-MI, is essential for improving outcomes.

Myocardial Infarction 52

Myocardial Infarction Preserved Ejection Fraction Heart Failure Aortic valve 52

DAIC

MAY 2, 2024

(‘Reprieve’), a development stage company focused on pioneering an intelligent approach to acute decompensated heart failure (ADHF) treatment, today highlighted the publication of TREAT-AHF study results in JACC: Heart Failure. Heart failure (HF) is a leading cause of hospitalization in the United States.

Heart Failure 105

Heart Failure Inpatient Hospital Research 105

JAMA Cardiology

NOVEMBER 16, 2024

This multicenter secondary analysis of the FINEARTS-HF randomized clinical trial examines the treatment effect of finerenone, relative to placebo, on clinical outcomes based on postrandomization potassium levels.

Heart Failure 103

Heart Failure Outcomes 103

Frontiers in Cardiovascular Medicine

JANUARY 13, 2025

ObjectiveThis network meta-analysis was to compare the efficacy of different drugs on cardiac function, renal function, and clinical outcomes in patients with acute heart failure (AHF) accompanied by renal dysfunction.MethodsPubMed, EMBASE, Cochrane Library, and Web of Science were searched to screen all clinical trials of AHF between January 1st 2001 (..)

Heart Failure 52

Heart Failure Cardiac Function Outcomes 52

HCPLive

AUGUST 1, 2024

Eli Lilly's tirzepatide showed a 38% reduction in heart failure outcomes and improved symptoms in adults with HFpEF and obesity in the phase 3 SUMMIT trial.

Heart Failure 69

Heart Failure Obesity Outcomes 69

DAIC

SEPTEMBER 19, 2024

recently announced that Digitiva, a non-invasive digital health solution for heart failure management, has been listed with the U.S. a smartphone app designed for heart failure patients and built on the Welldoc, Inc. tim.hodson Thu, 09/19/2024 - 09:42 Sept. 18, 2024 – Astellas Pharma Inc.

Heart Failure 105

Heart Failure Technology Biomarkers Innovation 105

Frontiers in Cardiovascular Medicine

JANUARY 22, 2025

IntroductionThe objective of this study was to examine the impact of ventricular assist device support as a bridge to heart transplantation in children with end-stage heart failure. The primary outcome was survival at the follow-up evaluation.

Heart Transplant 52

Heart Transplant Transplant Pediatrics Heart Failure 52

Open Heart

FEBRUARY 27, 2025

Background Iron deficiency (ID) is a highly prevalent comorbidity in patients with chronic and acute heart failure and is associated with worse clinical outcomes. We aimed to evaluate the prevalence and clinical characteristics of ID and its association with in-hospital congestion and postdischarge outcomes.

Heart Failure 52

Heart Failure Hospital Outcomes 52

DAIC

FEBRUARY 26, 2024

milla1cf Mon, 02/26/2024 - 12:40 February 26, 2024 — More than 6 million Americans live with heart failure , and about half have an enlarged left ventricle, which causes stress on the heart and less blood pumped with each heartbeat. Patients may experience trouble breathing and fatigue, and at times require hospitalization.

Heart Failure 119

Heart Failure Open-Heart Surgery Hospital Outcomes 119

Cardiovascular Diabetology

JULY 22, 2024

Heart failure with preserved ejection fraction (HFpEF) is a mortal clinical syndrome without effective therapies. Empagliflozin (EMPA) improves cardiovascular outcomes in HFpEF patients, but the underlying mec.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Heart Failure Outcomes Research 105

Frontiers in Cardiovascular Medicine

MARCH 5, 2025

IntroductionHeart failure (HF) with improved ejection fraction (HFimpEF) was shown to be related with improved outcome but increase of left ventricular ejection fraction (LVEF) in patients without HF is of less known clinical significance.

Heart Failure 52

Heart Failure Outcomes Academic Research 52

Open Heart

OCTOBER 31, 2024

Background Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Our findings suggest that monitoring and managing SUA could be crucial in improving patient with HF outcomes. Serum uric acid (SUA), a product of purine metabolism, has been implicated in HF progression.

Heart Failure 52

Heart Failure Kidney Disease Blood Pressure Biomarkers 52

HCPLive

MARCH 31, 2025

Justin Mark, MD, discusses an analysis of the FIGHT trial looking at racial and ethnic differences in heart failure outcomes.

Heart Failure 69

Heart Failure Outcomes Diabetes 69

DAIC

JULY 31, 2024

mtaschetta-millane Wed, 07/31/2024 - 06:00 July 31, 2024 — A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart & Vascular Institute, demonstrates the effectiveness of a newly developed scoring system in identifying patients with Heart Failure with Preserved Ejection Fraction (HFpEF).

Heart Failure 111

Heart Failure Preserved Ejection Fraction Research Hospital 111

Frontiers in Cardiovascular Medicine

MARCH 7, 2024

Background Belt electrode skeletal muscle electrical stimulation (B-SES) is an emerging therapy anticipated to yield more favorable outcomes than conventional neuromuscular electrical stimulation (NMES), owing to its larger stimulation area. However, information on its efficacy and safety in patients with heart failure remains limited.

Heart Failure 124

Heart Failure Obesity Heart Transplant Transplant 124

European Journal of Heart Failure

FEBRUARY 16, 2025

Baseline characteristics for the vericiguat global study in participants with chronic heart failure (VICTOR) trial. of participants had no prior hospitalization for heart failure. Conclusion The VICTOR trial enrolled the most optimally treated population in a phase III heart failure trial. beta-blockers, 94.3%

Heart Failure 40

Heart Failure Defibrillator Hospital Outcomes 40

DAIC

FEBRUARY 6, 2024

Matthew Segar co-authored a study in JACC Heart Failure led by his research and residency mentor, University of Texas Southwestern Medical Center's Dr. Ambarish Pandey , that utilized a machine learning-based-approach to identify, understand, and predict diuretic responsiveness in patients with acute decompensated heart failure (ADHF).

Heart Failure 111

Heart Failure Research Hospital Cardiovascular Disease 111

DAIC

MAY 28, 2024

milla1cf Tue, 05/28/2024 - 07:00 May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heart failure, according to research presented at Heart Failure 2024 , a scientific congress of the European Society of Cardiology (ESC).

Heart Failure 98

Heart Failure Quality of Life Research Blood Pressure 98

European Journal of Heart Failure

JANUARY 20, 2025

Remote patient monitoring in heart failure (HF). Abstract Aims Methods of non-invasive remote patient monitoring (RPM) for heart failure (HF) remain diverse. A random-effects meta-analysis assessed outcomes, and additional analyses identified effective RPM components.

Heart Failure 40

Heart Failure Hospital Education Technology 40

Science Daily - Heart Disease

AUGUST 22, 2024

The researchers looked at data from 4,286 people -- out of a total of 17,605 from the landmark Semaglutide and Cardiovascular Outcomes (SELECT) trial who were randomly assigned either semaglutide or a placebo -- who were followed up over an average of more than three years.

Heart Failure 126

Heart Failure Research Outcomes 126

American College of Cardiology

MARCH 31, 2025

25 in Chicago and simultaneously published in JACC.

Preserved Ejection Fraction 61

Preserved Ejection Fraction Kidney Disease Obesity Heart Failure 61

Circulation: Heart Failure

MARCH 14, 2025

Circulation: Heart Failure, Ahead of Print. The genotype-phenotype interdependence causes unpredictable phenotypic penetrance that results in a variety of signs and symptoms and patient outcomes. About 3% to 4% of patients with African ancestry carry this genetic predisposition to develop signs and symptoms of hATTR-CA.

Genetic predisposition 71

Genetic predisposition Heart Failure Biomarkers Circulation 71

HeartRhythm

SEPTEMBER 1, 2024

However, whether it delivers comparable efficacy with different capture sites in heart failure (HF) patients remains unclear. Left bundle branch pacing (LBBP) is a novel physiological pacing modality.

Heart Failure 75

Heart Failure Physiology Outcomes 75

DAIC

MAY 6, 2024

The primary outcome measure for the study is change in six-minute walk distance from Baseline to Week 12. Initially discovered and developed by Orion Corporation in Finland, intravenous levosimendan is approved in 60 countries outside the United States for use in hospitalized patients with acutely decompensated heart failure.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Heart Failure Pulmonary Hypertension 105

Med Page Today

DECEMBER 29, 2023

(MedPage Today) -- Breathing machines with adaptive servo-ventilation (ASV) did not improve survival or other clinical outcomes in patients with heart failure (HF) and reduced ejection fraction and sleep-disordered breathing, the phase III ADVENT.

Outcomes 113

Outcomes Heart Failure 113

European Journal of Heart Failure

FEBRUARY 27, 2025

Abstract In patients with heart failure, neurohumoral activation leads to increased renal sodium avidity across the entire renal tubules, resulting in a positive sodium and water balance, leading to decompensated heart failure requiring intravenous diuretics.

Heart Failure 79

Heart Failure Document Nursing Outcomes 79

European Journal of Heart Failure

NOVEMBER 29, 2023

ABSTRACT Aims Heart failure outcomes remain poor despite advances in therapy. The European Society of Cardiology Heart Failure III Registry (ESC HF III Registry) aims to characterize HF clinical features and outcomes and to assess implementation of guideline-recommended therapy in Europe and other ESC affiliated countries.

Heart Failure 75

Heart Failure Preserved Ejection Fraction Quality of Life Biomarkers 75

Journal of the American Heart Association

DECEMBER 31, 2024

BackgroundInfective endocarditis (IE) is still a fatal disease, and given its rarity, ongoing updates to patient characteristics and outcomes of IE are essential for providing precision diagnoses and effective treatments. The inhospital mortality rate was 14.5%, which significantly increased from 14.1% in 2016 to 15.4%

Outcomes 45

Outcomes Heart Failure Risk Factors 45